We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+6.95%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$132M
AUM Growth
+$9.81M
(+8%)
Cap. Flow
+$3.88M
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
31.07%
Holding
141
New
8
Increased
35
Reduced
44
Closed
7
Avg Time Held Equity + Options
8.3
quarters
Top 10 Avg Time Held Equity + Options
4.3
quarters
Top 20 Avg Time Held Equity + Options
6.8
quarters
Avg Time Held Equity only
8.3
quarters
Top 10 Avg Time Held Equity only
4.3
quarters
Top 20 Avg Time Held Equity only
6.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.63M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.55M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.29M |
| 4 |
KKR & Co
KKR
|
+$941K |
| 5 |
Omega Healthcare
OHI
|
+$856K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$1.73M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$830K |
| 3 |
Johnson Controls International
JCI
|
+$821K |
| 4 |
Spectra Energy Corp Wi
SE
|
+$571K |
| 5 |
Tapestry
TPR
|
+$462K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.21% |
| 2 | Real Estate | 16.84% |
| 3 | Healthcare | 12.91% |
| 4 | Technology | 12.84% |
| 5 | Financials | 10.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
Alibaba
BABA
$276B
| $1.86M | 1.4% |
+17,570
| New | +$1.63M |
2016 Q3
0 quarters
|
|
27
Apple
AAPL
$4.98T
| $1.69M | 1.27% |
59,648
| – | – |
2013 Q2
13 quarters
|
|
28
Redwood Trust
RWT
$383M
| $1.63M | 1.23% |
114,867
-900
| -0.8% | -$12.8K |
2013 Q2
13 quarters
|
|
29
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.51M | 1.14% |
106,100
-1,000
| -0.9% | -$13.9K |
2013 Q2
13 quarters
|
|
30
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$169M
| $1.5M | 1.13% |
88,728
+8,806
| +11% | +$145K |
2014 Q3
8 quarters
|
|
31
CHS Inc 8% Preferred Stock
CHSCP
$317M
| $1.47M | 1.11% |
44,357
-800
| -2% | -$26.9K |
2013 Q2
13 quarters
|
|
32
Devon Energy
DVN
$55.2B
| $1.43M | 1.08% |
32,403
+1,000
| +3% | +$40.6K |
2013 Q2
13 quarters
|
|
|
YHOO
33
DELISTED
Yahoo Inc
YHOO
| $1.38M | 1.04% |
32,050
-20,250
| -39% | -$830K |
2013 Q2
13 quarters
|
|
34
Healthpeak Properties
DOC
$13.1B
| $1.33M | 1% |
38,375
-549
| -1% | -$19.2K |
2013 Q2
13 quarters
|
|
|
TRIB
35
Trinity Biotech
TRIB
$5.12M
| $1.28M | 0.97% |
645
+38
| +6% | +$71K |
2013 Q2
13 quarters
|
|
36
Procter & Gamble
PG
$355B
| $1.25M | 0.95% |
13,975
-300
| -2% | -$26.1K |
2016 Q2
1 quarter
|
|
37
iShares Mortgage Real Estate ETF
REM
$452M
| $1.22M | 0.92% |
29,088
-125
| -0.4% | -$5.3K |
2013 Q2
13 quarters
|
|
38
BlackRock Core Bond Trust
BHK
$594M
| $1.11M | 0.84% |
78,154
-100
| -0.1% | -$1.41K |
2014 Q4
7 quarters
|
|
39
AT&T
T
$157B
| $1.1M | 0.83% |
35,719
+15
| +0% | +$474 |
2015 Q2
5 quarters
|
|
40
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$577M
| $1.07M | 0.81% |
47,369
| – | – |
2013 Q2
13 quarters
|
|
41
GE Aerospace
GE
$319B
| $1.04M | 0.78% |
7,317
-313
| -4% | -$46.7K |
2013 Q2
13 quarters
|
|
42
Emerson Electric
EMR
$91.2B
| $948K | 0.72% |
17,398
-250
| -1% | -$13.4K |
2016 Q2
1 quarter
|
|
43
Wells Fargo
WFC
$244B
| $943K | 0.71% |
21,300
-1,350
| -6% | -$64.6K |
2013 Q2
13 quarters
|
|
44
Merck
MRK
$350B
| $921K | 0.7% |
15,458
-419
| -3% | -$24.5K |
2013 Q2
13 quarters
|
|
45
SPDR Gold Trust
GLD
$141B
| $884K | 0.67% |
7,035
+5,000
| +246% | +$637K |
2015 Q3
4 quarters
|
|
46
iShares S&P 100 ETF
OEF
$20.8B
| $884K | 0.67% |
9,215
| – | – |
2013 Q2
13 quarters
|
|
|
47
Omega Healthcare
OHI
$13.7B
| $853K | 0.64% |
+24,075
| New | +$856K |
2016 Q3
0 quarters
|
|
|
SSW.PRD
48
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
| $846K | 0.64% |
33,900
+300
| +0.9% | +$7.7K |
2013 Q2
13 quarters
|
|
49
DELISTED
Kennedy-Wilson Holdings
KW
| $789K | 0.6% |
35,000
| – | – |
2013 Q2
13 quarters
|
|
50
Terex
TEX
$6.08B
| $760K | 0.57% |
29,900
-1,100
| -4% | -$25.6K |
2014 Q3
8 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, Benchmark Capital Advisors held 141 positions worth $132M, up 8% from $123M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Benchmark Capital Advisors's Q3 2016 filing shows 8 new, 35 increased, 44 reduced and 7 closed positions. Its largest new stake was Alibaba: 17,570 shares worth $1.86M. The largest sale was Sarepta Therapeutics, an estimated $1.73M.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 18% a quarter earlier, followed by Real Estate and Healthcare.
- Benchmark Capital Advisors's largest Q3 2016 buy was Alibaba: 17,570 shares worth $1.86M.
- Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q3 2016, an estimated $1.55M increase.
- Benchmark Capital Advisors's biggest Q3 2016 reduction was Sarepta Therapeutics, cutting an estimated $1.73M.
- Benchmark Capital Advisors fully exited Johnson Controls International in Q3 2016, selling an estimated $821K.
- Benchmark Capital Advisors's ten largest holdings make up 31% of its $132M portfolio in Q3 2016.
- Benchmark Capital Advisors opened 8 new positions and closed 7 in Q3 2016.
- Benchmark Capital Advisors's portfolio value rose 8% quarter-over-quarter to $132M.
Based on Benchmark Capital Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.